Additional file 2: of The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting
收藏NIAID Data Ecosystem2026-03-10 收录
数据链接：
官方服务：
资源简介：
I-SPY 2 Trial participating sites and institutional review boards (IRB). (XLSX 48 kb)
创建时间：
2017-08-30
